| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_845acdfd2ede922b949657f4e8d46a30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11c91a4059a0b60a7421e3f47dd5874b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5de563574dda94dc8e054f02e5b5c736 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
| filingDate |
2000-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca9adb2f7e4aa2d75fb9918305850184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc3387836e01c20b183db5bb042c4046 |
| publicationDate |
2001-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0113714-A2 |
| titleOfInvention |
Prostatic cell line and animal model of a prostatic tumor |
| abstract |
The invention relates to a method for producing a non-human A mammal with a prostatic tumor. The invention also relates to a prostatic tumor and an established cell line which can form a prostatic tumor in dogs after grafting has occurred. The invention further relates to specific monoclonal antibodies of prostatic tumoral cells and to the use thereof in diagnosis or therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9901713-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10974029-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10058681-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10300268-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10086193-B2 |
| priorityDate |
1999-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |